Determinants of insulin-resistant phenotypes in normal-weight and obese black african women

Obesity

Volumn 16, Issue 7, 2008, Pages 1602-1609

  Jennings, Courtney L ^a   Lambert, Estelle V ^a   Collins, Malcolm ^a,b   Joffe, Yael ^a   Levitt, Naomi S ^c   Goedecke, Julia H ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; ENERGY METABOLISM; ETHNOLOGY; FEMALE; HEALTH; HUMAN; INJECTION; INSULIN RESISTANCE; MOTOR ACTIVITY; NEGRO; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; QUESTIONNAIRE; REFERENCE VALUE; RISK FACTOR; SOCIOECONOMICS; SOUTH AFRICA; STATISTICS;

ADIPOSITY; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BODY WEIGHT; CONTRACEPTIVE AGENTS, FEMALE; ENERGY METABOLISM; FEMALE; HUMANS; INJECTIONS; INSULIN RESISTANCE; MOTOR ACTIVITY; OBESITY; PHENOTYPE; QUESTIONNAIRES; REFERENCE VALUES; RISK FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA; URBAN HEALTH;

EID: 46249087844     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.233     Document Type: Article

References (45)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
2. Puoane T, Steyn K, Bradshaw D et al. Obesity in South Africa: the South African demographic and health survey. Obes Res 2002;10:1038-1048.
3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583-2589.
4. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004;30:569-572.
5. Karelis AD, Brochu M, Rabasa-Lhoret R, Garrel D, Poehlman ET. Clinical markers for the identification of metabolically healthy but obese individuals. Diabetes Obes Metab 2004;6:456-457.
6. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005;13:1116-1122.
7. Walker AR, Walker BF, Walker AJ, Vorster HH. Low frequency of adverse sequelae of obesity in South African rural black women. Int J Vitam Nutr Res 1989;59:224-228.
8. Walker AR, Walker BF, Manetsi B, Tsotetsi NG, Walker AJ. Obesity in black women in Soweto, South Africa: minimal effects on hypertension, hyperlipidaemia and hyperglycaemia. J R Soc Health 1990;110:101-103.
9. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
10. Brochu M, Tchernof A, Dionne IJ et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001;86:1020-1025.
11. Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:1714-1721.
12. Karelis AD, St Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-2575.
13. Van der Merwe MT, Schlaphoff GP, Crowther NJ et al. Lactate and glycerol release from adipose tissue in lean, obese, and diabetic women from South Africa. J Clin Endocrinol Metab 2001;86:3296-3303.
14. Rush EC, Goedecke JH, Jennings C et al. BMI, fat and muscle differences in urban women of five ethnicities from two countries. Int J Obes (Lond) 2007;31:1232-1239.
15. Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
16. Conus F, Allison DB, Rabasa-Lhoret R et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-5020.
17. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214.
18. Snijder MB, Zimmet PZ, Visser M et al. Independent association of hip circumference with metabolic profile in different ethnic groups. Obes Res 2004;12:1370-1374.
19. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese, " normal-weight individual. Am J Clin Nutr 1981;34:1617-1621.
20. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
22. St Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004;27:2222-2228.
23. Steyn K, Jooste PL, Bourne L et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. The BRISK study. S Afr Med J 1991;79:480-485.
24. Bull F. GPAQ Reliability and Validity Research Program: Data Analysis Manual Version 1. 3-3-2003. School of Movement and Exercise Science, University of Western Australia.
25. Smith SR, Lovejoy JC, Greenway F et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001;50:425-435.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
27. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
28. Sumner AE, Vega GL, Genovese DJ et al. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 2005;54:902-909.
29. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005;165:1395-1400.
30. Pate RR, Pratt M, Blair SN et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402-407.
31. Haskell WL, Lee IM, Pate RR et al. Physical activity and public health. updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1081-1093.
32. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
33. Van der Merwe MT, Crowther NJ et al. Evidence for insulin resistance in black women from South Africa. Int J Obes Relat Metab Disord 2000;24:1340-1346.
34. Isezuo SA. Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes? Ethn Dis 2005;15:6-10.
35. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2007;196:696-703.
36. Seftel HC, Asvat MS, Joffe BI et al. Selected risk factors for coronary heart disease in male scholars from the major South African population groups. S Afr Med J 1993;83:891-897.
37. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176.
38. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996;45:1119-1124.
39. Smith SR, Ravussin E. Emerging paradigms for understanding fatness and diabetes risk. Curr Diab Rep 2002;2:223-230.
40. Nyholm B, Mengel A, Nielsen S et al. Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia 1996;39:813-822.
41. Katzel LI, Bleecker ER, Colman EG et al. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 1995;274:1915-1921.
42. Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 1997;13:3-13.
43. Cooper D, Marks AS. Community-based distribution of contraception: a pilot project in Khayelitsha, Cape Town. Urban Health Newsl 1996;49-55.
44. Kahn HS, Curtis KM, Marchbanks PA. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. Diabetes Care 2003;26:216-225.
45. Clark MK, Dillon JS, Sowers M, Nichols S. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes (Lond) 2005;29:1252-1258.